“…In our study, we did not nd any of the well-described variants in ACE1, ACE2, IFNAR2, TYK2, OAS1, OAS3, CD40, FCGR2A, CASP3, DPP9, TLR2, TLR3, TLR4, TLR7, TLR8, and TLR9 associated with prognosis and susceptibility to COVID-19 infection [31][32][33] , but we have detected known mutations in genes related to cardiovascular disease (SCN5A, LDLR, DSG2), primary ciliary dyskinesia (DNAH5, DNAH, CCDC103), cystic brosis (CFTR), DNA damage repair response (CHEK2), coagulation (F7, F11, G6PD, PROC), primary immune disorder (TNFRSF1A, COL7A1, LZTR1, CASP10), hemoglobin subunit β (HBB), and other genes (COL9A3, MUC5B), associated with severe COVID-19. We have detected ultra-rare variants (MAF < 0.01%) in immune response-related genes, MUC5AC, ABCA7, FLNA, already associated with the host response to COVID-19 33 .…”